Extracellular DJ-1 induces sterile inflammation in the ischemic brain
K. Nakamura, S. Sakai, J. Tsuyama, A. Nakamura, K. Otani, K. Kurabayashi, Y. Yogiashi, H. Masai, T. Shichita
Abstract
Inflammation is implicated in the onset and progression of various diseases, including cerebral pathologies. Here we report that DJ-1, which plays a role within cells as an antioxidant protein, functions as a damage-associated molecular pattern (DAMP), and triggers inflammation if released from dead cells into the extracellular space. We first found that recombinant DJ-1 protein induces the production of various inflammatory cytokines in bone marrow-derived macrophages (BMMs). We further identified a unique peptide sequence in the G and H helices of DJ-1 that activates Toll-like receptor 2 (TLR2) and TLR4. In the ischemic brain, DJ-1 is released into the extracellular space from necrotic neurons within 24 hours after stroke onset and makes direct contact with the surfaces of infiltrating myeloid cells. Administration of an antibody against DJ-1 suppresses the expression of inflammatory cytokines in infiltrating immune cells and attenuates ischemic neuronal damage. Our results demonstrate a previously unknown function of DJ-1 as a DAMP and suggest that extracellular DJ-1 could be a therapeutic target to prevent inflammation in tissue injuries and neurodegenerative diseases. Significance statementDJ-1 has been thoroughly investigated as a cytoprotective antioxidant protein in neurons. However, here we demonstrate that extracellularly released DJ-1 triggers neurotoxic inflammation after ischemic stroke. Intracellular DJ-1 increases in response to oxidative stress in ischemic neurons, but if ischemic stresses result in necrotic cell death, DJ-1 is released extracellularly. Released DJ-1 interacts with TLR2 and TLR4 on the surface of infiltrating myeloid cells and triggers post-ischemic inflammation, leading to the exacerbated pathologies of ischemic stroke. Thus, extracellular DJ-1 is a previously unknown inflammatogenic DAMP, and may be a putative target for therapeutic intervention to prevent progression of inflammatory and neurodegenerative diseases.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Specific deletion of interleukin-1 beta in microglia improves acute outcome and modulates neurogenesis after ischemic stroke
Alba Grayston, Margarida Baptista, … Emmanuel Pinteaux·GliaPeer-reviewed·May 28, 2026
- Selective deletion of interleukin-1 alpha in microglia does not modify acute outcome but regulates neurorepair processes after experimental ischemic stroke.
Eloïse Lemarchand, Alba Grayston, … Emmanuel Pinteaux·bioRxiv·Feb 16, 2024
- The importance of selected markers of inflammation and blood-brain barrier damage for short-term post-stroke prognosis
Anetta Lasek‐Bal, Halina Jędrzejowska–Szypułka, … Joanna Lewin‐Kowalik·bioRxiv·Dec 21, 2018
- DRP1 induces neuroinflammation via transcriptional regulation of NF-ĸB
Yanhao Lai, Rebecca Zhangqiuzi Fan, … Kim Tieu·Nature CommunicationsPeer-reviewed·Mar 16, 2026
- JNK-IN-8, a c-Jun N-terminal kinase inhibitor, improves functional recovery through suppressing neuroinflammation in ischemic stroke
- Juxtacrine DLL4-NOTCH1 signaling between astrocytes drives neuroinflammation via the IL-6-STAT3 axis
Pierre Mora, Margaux Laisné, … Candice Chapouly·bioRxiv·Oct 4, 2023